EEG-PHARMACOLOGICAL AND NEUROPSYCHOLOGICAL STUDY OF (-)EBURNAMONINE IN PATIENTS WITH CHRONIC CEREBROVASCULAR DISORDERSMANNA V; CONTI L; MARTUCCI N et al.1982; CURR. THER. RES.; ISSN 0011-393X; USA; DA. 1982; VOL. 32; NO 5; PP. 740-751; BIBL. 18 REF.Article

CORRELATIONS DU SPECTRE E.E.G. ET DE LA PROLACTINE PLASMATIQUE CHEZ LE SUJET AGEAGNOLI A; MARTUCCI N; BALDASSARE M et al.1980; REV. ELECTROENCEPHALOGR. NEUROPHYSIOL. CLIN.; ISSN 0370-4475; FRA; DA. 1980; VOL. 10; NO 3; PP. 242-248; ABS. ENG; BIBL. 10 REF.Article

L'ELETTROENCEFALOGRAMMA COMPUTERIZZATO NELLA VALUTAZIONE DELL'ATTIVITA DEI FARMACI VASOATTIVI E EUMETABOLICI NEI DISTURBI CEREBRO-VASCOLARI CRONICI = L'ELECTROENCEPHALOGRAMME TRAITE PAR ORDINATEUR DANS L'EVALUATION DE L'ACTIVITE DES MEDICAMENTS VASOACTIFS ET EUMETABOLIQUES, DANS LES TROUBLES CEREBROVASCULAIRES CHRONIQUESMARTUCCI N; BOCOLA V; MEARELLI S et al.1980; RIV. NEUROL.; ITA; DA. 1980; VOL. 50; NO 2; PP. 73-97; ABS. FRE/ENG/GER; BIBL. 3 P.Article

Double-blind study on the hypnotic and antianxiety effects of zopiclone compared with nitrazepam in the treatment of insomniaAGNOLI, A; MANNA, V; MARTUCCI, N et al.International journal of clinical pharmacology research. 1989, Vol 9, Num 4, pp 277-281, issn 0251-1649Article

Quantitative EEG as a tool in neuropharmacological studies: the effect of naftidrofuryl in chronic cerebrovascular diseases (C.C.V.D.)AGNOLI, A; MARTUCCI, N; MANNA, V et al.Current therapeutic research. 1985, Vol 37, Num 3, pp 387-397, issn 0011-393XArticle

Neuroleptic induced parkinsonism : MRI findings in relation to clinical course after withdrawal of neuroleptic drugsBOCOLA, V; FABBRINI, G; SOLLECITO, A et al.Journal of neurology, neurosurgery and psychiatry. 1996, Vol 60, Num 2, pp 213-216, issn 0022-3050Article

Antipanic effect of fluoxetine measured by CO₂ challenge testBOCOLA, V; TRECCO, M. D; FABBRINI, G et al.Biological psychiatry (1969). 1998, Vol 43, Num 8, pp 612-615, issn 0006-3223Article

Incidência de doença diverticular do intestino grosso em individuos não chagásicos e em chagàsicos com e sem megacólon = Incidence de la maladie diverticulaire du côlon chez des sujets non chagasiques et chagasiques avec et sans mégacôlon = Incidence of diverticular disease of the large bowel among non chagasic individuals and chagasic patients with of without megacolonMENEGHELLI, U. G; MARTINELLI, A. L. C; MARTUCCI, N. C et al.Arquivos de gastroenterologia. 1986, Vol 23, Num 1, pp 3-8, issn 0004-2803Article

Randomized double-blind study of flunarizine versus placebo in patients with chronic cerebrovascular disordersAGNOLIA, A; MARTUCCI, N; FIORAVANTI, M et al.International journal of clinical pharmacology research. 1988, Vol 8, Num 3, pp 189-197, issn 0251-1649Article

Posatirelin in the treatment of vascular dementia : a double-blind multicentre study vs placeboPARNETTI, L; AMBROSOLI, L; POLI, A et al.Acta neurologica scandinavica. 1996, Vol 93, Num 6, pp 456-463, issn 0001-6314Article

Preventive treatment of headache with slow-release dihydroergotamine : comparison of dosage protocolsBUSCAINO, G. A; SORGE, F; PUCA, F. M et al.Current therapeutic research. 1991, Vol 49, Num 6, pp 925-935, issn 0011-393X, 11 p.Article

Epidemiologische Studie zur Wirksamkeit und Verträglichkeit von Dihydroergocristin bei Verschlechterung der Gedächtnis- und der Verhaltensfunktionen beim älteren Menschen = Epidemiological study on the efficacy and safety of dihydroergocristine in impaired memory and behavioural functions in the elderlyABATE, G; ANGELERI, F; CONGIA, S et al.Arzneimittel-Forschung. 1992, Vol 42, Num 11A, pp 1417-1421, issn 0004-4172Article